Prospective cognitive follow-up in primary CNS lymphoma patients treated with chemotherapy and reduced-dose radiotherapy

Journal of Neuro-Oncology

Volumn 91, Issue 3, 2009, Pages 315-321

  Correa, Denise D ^a   Rocco Donovan, Mary ^a   DeAngelis, Lisa M ^a   Dolgoff Kaspar, Rima ^b   Iwamoto, Fabio ^a   Yahalom, Joachim ^a   Abrey, Lauren E ^a  

^a MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

^b UNIVERSITY OF ARIZONA COLLEGE OF MEDICINE   (United States)

Author keywords

Chemotherapy; Cognitive; Neuropsychological assessment; Primary CNS lymphoma; Radiotherapy

Indexed keywords

ANTICONVULSIVE AGENT; CORTICOSTEROID; CYTARABINE; METHOTREXATE; PROCARBAZINE; RITUXIMAB; VINCRISTINE;

ADULT; AGED; ARTICLE; CANCER CHEMOTHERAPY; CANCER RADIOTHERAPY; CLINICAL ARTICLE; CLINICAL TRIAL; COGNITIVE DEFECT; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOSE RESPONSE; DRUG DOSE REDUCTION; DRUG MEGADOSE; DRUG WITHDRAWAL; FEMALE; FOLLOW UP; HUMAN; MALE; MEMORY DISORDER; MENTAL DETERIORATION; MENTAL DISEASE; MENTAL FUNCTION; MOTOR DYSFUNCTION; MOTOR PERFORMANCE; MULTIPLE CYCLE TREATMENT; NEUROPSYCHOLOGICAL TEST; OUTCOME ASSESSMENT; PRIMARY CENTRAL NERVOUS SYSTEM LYMPHOMA; RADIATION DOSE; SEIZURE; TREATMENT RESPONSE; TUMOR VOLUME; VERBAL MEMORY; WHOLE BODY RADIATION;

AGED; CENTRAL NERVOUS SYSTEM NEOPLASMS; COGNITION DISORDERS; DRUG THERAPY; FEMALE; FOLLOW-UP STUDIES; HUMANS; LYMPHOMA; MAGNETIC RESONANCE IMAGING; MALE; MEMORY; MIDDLE AGED; MOTOR ACTIVITY; NEUROPSYCHOLOGICAL TESTS; PROBLEM SOLVING; PROSPECTIVE STUDIES; RADIOTHERAPY; TIME FACTORS; VERBAL LEARNING;

EID: 58149472908     PISSN: 0167594X     EISSN: 15737373     Source Type: Journal    
DOI: 10.1007/s11060-008-9716-0     Document Type: Article

References (28)

1. Abrey LE, DeAngelis LM, Yahalom J (1998) Long-term survival in primary CNS lymphoma. J Clin Oncol 16:859-863
2. Deangelis LM, Seiferheld W, Schold SC et al (2002) Combination chemotherapy and radiotherapy for primary central nervous lymphoma: Radiation Therapy Oncology Group 93-100. J Clin Oncol 21:4643-4648. doi: 10.1200/JCO.2002.11.013
3. Behin A, Delattre J-Y (2003) Neurologic sequelae of radiotherapy on the nervous system. In: Schiff D, Wen PY (eds) Cancer Neurology in clinical practice. Humana Press Inc, Totowa, NJ, pp 173-191
4. Tuxen MK, Hansen SW (1994) Neurotoxicity secondary to antineoplastic drugs. Cancer Treat Rev 20:191-214. doi: 10.1016/0305-7372(94)90027-2
5. Santarelli L, Saxe M, Gross C et al (2003) Requirement of hippocampal neurogenesis for the behavioral effects of antidepressants. Science 301:805-809. doi: 10.1126/science.1083328
6. Dietrich J, Han R, Yang Y et al (2006) CNS progenitor cells and oligodendrocytes are targets of chemotherapeutic agents in vitro and vivo. J Biol 5:1-23. doi: 10.1186/jbiol50
7. Monje ML, Vogel H, Masek M et al (2007) Impaired human hippocampal neurogenesis after treatment for central nervous system malignancies. Ann Neurol 62:515-520. doi: 10.1002/ana.21214
8. Winocur G, Wojtowicz JM, Sekeres M et al (2006) Inhibition of neurogenesis interferes with hippocampus-dependent memory function. Hippocampus 16:296-304. doi: 10.1002/hipo.20163
9. Correa DD, Maron L, Harder H et al (2007) Cognitive functions in primary central nervous system lymphoma: Literature review and assessment guidelines. Ann Oncol 18:1145-1151. doi: 10.1093/annonc/mdl464
10. Shah GD, Yahalom J, Correa DD et al (2007) Combined immunochemotherapy with reduced whole-brain radiotherapy for newly diagnosed primary CNS lymphoma. J Clin Oncol 25:4730-4735. doi: 10.1200/JCO.2007.12.5062
11. Correa DD, DeAngelis LM, Shi W et al (2004) Cognitive functions in survivors of primary central nervous system lymphoma. Neurology 62:548-555
12. Fazekas F, Chawluk JB, Alavi A et al (1987) MR signal abnormalities at 1.5 T in Alzheimer's dementia and normal aging. AJNR Am J Neuroradiol 8:421-426
13. Blair JR, Spreen O (1989) Predicting premorbid IQ: A revision of the National Adult Reading Test. Clin Neuropsychol 3:129-136. doi: 10.1080/ 13854048908403285
14. Barona A, Reynolds CR, Chastain R (1984) A demographically based index of premorbid intelligence for the WAIS-R. J Consult Clin Psychol 52:885-887. doi: 10.1037/0022-006X.52.5.885
15. Fliessbach K, Helmstaedter C, Urbach H et al (2005) Neuropsychological outcome after chemotherapy for primary CNS lymphoma: A prospective study. Neurology 64:1184-1188
16. Schlegel U, Pels H, Glasmacher A et al (2001) Combined systemic and intraventricular chemotherapy in primary CNS lymphoma: A pilot study. J Neurol Neurosurg Psychiatry 71:118-122. doi: 10.1136/jnnp.71.1.118
17. McAllister LD, Doolittle ND, Guastadisegni PE et al (2000) Cognitive outcomes and long-term follow-up results after enhanced chemotherapy delivery for primary central nervous system lymphoma. Neurosurgery 46:51-61. doi: 10.1097/00006123-200001000-00010
18. Aldenkamp AP (2001) Effects of antiepileptic drugs on cognition. Epilepsia 41:46-49. doi: 10.1046/j.1528-1157.2001.00516.x
19. Young AH, Sahakian BJ, Robbins TW et al (1999) The effects of chronic administration of hydrocortisone on cognitive function in normal male volunteers. Psychopharmacology 145:260-266. doi: 10.1007/s002130051057
20. Harder H, Holtel H, Bromberg JEC et al (2004) Cognitive status and quality of life after treatment for primary CNS lymphoma. Neurology 62:544-555
21. Omuro AMP, Ben-Porat LS, Panageas KS et al (2005) Delayed neurotoxicity in primary central nervous system lymphoma. Arch Neurol 62:1595-1600. doi: 10.1001/archneur.62.10.1595
22. Corry J, Smith JG, Wirth A et al (1998) Primary central nervous system lymphoma: Age and performance status are more important than treatment modality. Int J Radiat Oncol Biol Phys 41:615-620. doi: 10.1016/ S0360-3016(97)00571-3
23. Poortmans PMP, Kluin-Nelemans HC, Haaxma-Reiche H et al (2003) High-dose methotrexate-based chemotherapy followed by consolidating radiotherapy in non-AIDS-related primary central nervous system lymphoma: European organization for research and treatment of cancer lymphoma group phase II trial 20962. J Clin Oncol 21:4483-4488. doi: 10.1200/JCO.2003.03.108
24. Tullberg M, Fletcher E, DeCarli C et al (2004) White matter lesions impair frontal lobe function regardless of their location. Neurology 63:246-253
25. Monje ML, Palmer T (2003) Radiation injury and neurogenesis. Curr Opin Neurol 16:129-134. doi: 10.1097/00019052-200304000-00002
26. Andres-Mach M, Rola R, Fike JR (2008) Radiation effects on neural precursor cells in the denate gyrus. Cell Tissue Res 331:251-262. doi: 10.1007/s00441-007-0480-9
27. Rzeski W, Pruskil S, Macke A et al (2004) Anticancer agents are potent neurotoxins in vivo and in vitro. Ann Neurol 56:351-360. doi: 10.1002/ ana.20185
28. Snyder JS, Hong NS, McDonald RJ, Wojtowicz JM (2005) A role for adult neurogenesis in spatial long-term memory. Neuroscience 130:843-852. doi: 10.1016/j.neuroscience.2004.10.009